SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFM14A - Definitive proxy statement relating to merger or acquisition:
SEC Accession No. 0001193125-23-012549
Filing Date
2023-01-23
Accepted
2023-01-23 06:59:33
Documents
7

Document Format Files

Seq Description Document Type Size
1 DEFM14A d418961ddefm14a.htm DEFM14A 2241331
2 GRAPHIC g418961g01m01.jpg GRAPHIC 214613
3 GRAPHIC g418961g02m02.jpg GRAPHIC 305281
4 GRAPHIC g418961g03m03.jpg GRAPHIC 256851
5 GRAPHIC g418961g04m04.jpg GRAPHIC 314354
6 GRAPHIC g418961g06y90.jpg GRAPHIC 29387
7 GRAPHIC g418961g40h45.jpg GRAPHIC 50040
  Complete submission text file 0001193125-23-012549.txt   3855047
Mailing Address CONNAUGHT HOUSE, 1ST FLOOR 1 BURLINGTON ROAD DUBLIN L2 4
Business Address CONNAUGHT HOUSE, 1ST FLOOR 1 BURLINGTON ROAD DUBLIN L2 4 011-353-1-772-2100
Horizon Therapeutics Public Ltd Co (Filer) CIK: 0001492426 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: DEFM14A | Act: 34 | File No.: 001-35238 | Film No.: 23542494
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences